AMD is the leading cause of irreversible blindness in the world and is growing globally.

Our Mission is to find a treatment for the dry form of AMD, which currently has no treatment options. Our Vision is to do this efficiently and effectively through the art of translation, bringing novel treatments from the scientific bench to the patient in the clinic, by strategically aligning our development program to address the field’s greatest needs.


Clinical Stage Ophthalmic Bioimaging & Health Tech Company